These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32624192)

  • 1. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
    Guzman-Prado Y
    Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
    [No Abstract]   [Full Text] [Related]  

  • 2. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
    Jeevaratnam K
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):256-257. PubMed ID: 32347923
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
    Sahraei Z; Shabani M; Shokouhi S; Saffaei A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
    [No Abstract]   [Full Text] [Related]  

  • 4. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
    Guastalegname M; Vallone A
    Clin Infect Dis; 2020 Jul; 71(15):888-889. PubMed ID: 32211771
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
    Ruamviboonsuk P; Lai TYY; Chang A; Lai CC; Mieler WF; Lam DSC
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):375-376. PubMed ID: 32740072
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
    Gao J; Hu S
    Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19.
    Wiwanitkit V
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):374. PubMed ID: 32740070
    [No Abstract]   [Full Text] [Related]  

  • 8. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
    D'Acquarica I; Agranat I
    Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
    [No Abstract]   [Full Text] [Related]  

  • 9. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
    Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
    Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
    [No Abstract]   [Full Text] [Related]  

  • 10. Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
    Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
    Ann Intern Med; 2020 Aug; 173(4):W78-W79. PubMed ID: 32667853
    [No Abstract]   [Full Text] [Related]  

  • 11. The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
    Frishman WH
    Cardiol Rev; 2020; 28(5):217-218. PubMed ID: 32639241
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
    Piszczatoski CR; Powell J
    Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
    Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
    Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
    Allam MF; Andraous F
    Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
    [No Abstract]   [Full Text] [Related]  

  • 16. Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.
    Decloedt EH; Reuter H; Allwood B; Parker A; Koegelenberg CFN; Blockman M; Taljaard J
    S Afr Med J; 2020 Apr; 110(5):12903. PubMed ID: 32657706
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 and hydroxychloroquine: Let the available data speak for themselves.
    Paliani U; Cardona A
    Eur J Intern Med; 2020 Oct; 80():121. PubMed ID: 32709544
    [No Abstract]   [Full Text] [Related]  

  • 18. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
    Principi N; Esposito S
    Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322
    [No Abstract]   [Full Text] [Related]  

  • 19. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
    Lebin JA; LeSaint KT
    West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update Alert 2: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
    Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
    Ann Intern Med; 2020 Oct; 173(7):W128-W129. PubMed ID: 32853033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.